BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12133598)

  • 1. Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures.
    Teather LA; Lee RK; Wurtman RJ
    Brain Res; 2002 Aug; 946(1):87-95. PubMed ID: 12133598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 mediates platelet-activating factor-induced prostaglandin E2 release from rat primary astrocytes.
    Teather LA; Wurtman RJ
    Neurosci Lett; 2003 Apr; 340(3):177-80. PubMed ID: 12672535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PAF-induced tPA release by KO-286011.
    Klöcking HP
    Ann N Y Acad Sci; 1992 Dec; 667():202-3. PubMed ID: 1309038
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei.
    Grassi S; Francescangeli E; Goracci G; Pettorossi VE
    J Neurophysiol; 1998 Jun; 79(6):3266-71. PubMed ID: 9636125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activating factor induces dopamine release in PC-12 cell line.
    Bussolino F; Tessari F; Turrini F; Braquet P; Camussi G; Prosdocimi M; Bosia A
    Am J Physiol; 1988 Oct; 255(4 Pt 1):C559-65. PubMed ID: 3177629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex.
    Marcheselli VL; Rossowska MJ; Domingo MT; Braquet P; Bazan NG
    J Biol Chem; 1990 Jun; 265(16):9140-5. PubMed ID: 2160958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of platelet activating factor antagonists on cultured rat mesangial cells.
    Neuwirth R; Singhal P; Satriano JA; Braquet P; Schlondorff D
    J Pharmacol Exp Ther; 1987 Nov; 243(2):409-14. PubMed ID: 3119816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures.
    Nogami K; Hirashima Y; Endo S; Takaku A
    Brain Res; 1997 Apr; 754(1-2):72-8. PubMed ID: 9134961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosanoid and inositol phosphate response to platelet-activating factor (PAF) and to a PAF antagonist in rat astroglial cells.
    Petroni A; Salami M; Blasevich M; Papini N; Galella G; Colombo C; Galli C
    Brain Res Dev Brain Res; 1994 Apr; 78(2):169-74. PubMed ID: 8026072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
    Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
    Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
    Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
    Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S; Braquet P; Sirois P
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet-activating factor (PAF) in the initiation of the decidual reaction in the rat.
    Acker G; Braquet P; Mencia-Huerta JM
    J Reprod Fertil; 1989 Mar; 85(2):623-9. PubMed ID: 2703999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures.
    Rougier F; Dupuis F; Cornu E; Dulery C; Praloran V; Denizot Y
    J Lipid Mediat Cell Signal; 1997 Jul; 16(3):147-53. PubMed ID: 9246604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor receptor stimulation disrupts neuronal migration In vitro.
    Bix GJ; Clark GD
    J Neurosci; 1998 Jan; 18(1):307-18. PubMed ID: 9412509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
    Hostettler ME; Knapp PE; Carlson SL
    Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia.
    Yoshida H; Imaizumi T; Tanji K; Sakaki H; Metoki N; Hatakeyama M; Yamashita K; Ishikawa A; Taima K; Sato Y; Kimura H; Satoh K
    Brain Res Mol Brain Res; 2005 Jan; 133(1):95-101. PubMed ID: 15661369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.